IGF2BP3 and colorectal carcinoma: IGF2BP3 showed a spatiotemporal expression pattern of “high expression during embryogenesis, inhibited expression in the normal intestinal mucosa, and upregulated expression in CRC tissues,” suggesting that IGF2BP3 might be involved in tumorigenesis and tumor progression of CRC.